SAVE Trial - Use of the Selution Sirolimus Eluting Balloon for Dysfunctional AV accEss Treatment Indications — SAVE

AV Fistula Clinical Trial

Official title:
SAVE Trial - Use of the Selution Sirolimus Eluting Balloon for Dysfunctional AV accEss Treatment Indications

Status Active, not recruiting

Clinical Trial Summary

Prospective multi-center single-blinded randomized controlled trial (RCT) investigating the safety and feasibility of the SELUTION SLR™ (Sustained Limus Release) 018 drug eluting balloon (DEB) for the treatment of failed AV fistula in renal dialysis patients. Patients will be randomised to either SELUTION SLR or POBA.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04327609
Study type	Interventional
Source	M.A. Med Alliance S.A.
Contact
Status	Active, not recruiting
Phase	N/A
Start date	April 10, 2020
Completion date	December 31, 2025

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05462223` - Alucent Vessel Restoration System for AVF	N/A
Completed	`NCT02363972` - Percutaneous Less Invasive AV Fistula for Vascular Access in ESRD	N/A
Terminated	`NCT04626427` - The WavelinQ™ Arterio-Venous Endovascular Fistula: A Global, Post-Market Investigation	N/A
Completed	`NCT01471041` - Safety and Efficacy Study of the Venous Window Needle Guide to Access Arteriovenous (AV)Fistulae	Phase 2/Phase 3
Not yet recruiting	`NCT05569109` - av Fistula Patency Loss as a Cause of Fistula Failure and Hyperphosphatemia
Completed	`NCT02475837` - Vorapaxar Study for Maturation of AV Fistulae for Hemodialysis Access	Phase 2
Active, not recruiting	`NCT04484220` - Ellipsys Vascular Access System Post Market Surveillance (PS) Study	N/A